Process for making amino acid compounds

US9278917B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9278917-B2
Application numberUS-201314401095-A
CountryUS
Kind codeB2
Filing dateMay 17, 2013
Priority dateMay 17, 2012
Publication dateMar 8, 2016
Grant dateMar 8, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides new processes for making and purifying amino acid compounds, which are useful in the preparation of AKT inhibitors used in the treatment of diseases such as cancer, including the compound (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one.

First claim

Opening claim text (preview).

I claim: 1. A process comprising reducing a compound of formula II, or a salt thereof: wherein: R 1 and R 2 are independently hydrogen, C 1 -C 12 alkyl or an amino protecting group to form a compound of formula I: or a salt thereof. 2. The process of claim 1 , further comprising hydrolyzing a compound of formula III, or salt thereof: wherein: R 3 is optionally substituted C 1 -C 12 alkyl, to form a compound of formula II. 3. The process of claim 2 , further comprising reacting a compound of formula IV, or a salt or tautomer thereof: with —NHR 1 R 2 or a salt thereof, to form a compound of formula III, or a salt thereof. 4. The process of claim 3 , wherein NHR 1 R 2 is —NH(isopropyl). 5. The process of claim 3 further comprising contacting a compound of formula V or a salt thereof: with HCO 2 R 4 , wherein R 4 is optionally substituted C 1 -C 12 alkyl, or a salt thereof, under basic conditions, to form a compound of formula IV, or a salt thereof. 6. The process of claim 5 , wherein said basic conditions comprise a base selected from hydroxide or alkoxide base. 7. The process of claim 1 , wherein R 1 is an amino protecting group. 8. The process of claim 1 , wherein said amino protecting group is selected from acetyl, trifluoroacetyl, phthalimide, benzyl, triphenylmethyl, benzylidenyl, p-toluenesulfonyl, p-methoxybenzyl, tert-butyloxycarbonyl, 9-fluorenylmethyloxycarbonyl and carbobenzyloxy. 9. The process of claim 1 , wherein R 1 is tert-butyloxycarbonyl and R 2 is isopropyl. 10. The process of claim 1 , wherein said reducing comprises contacting a compound of formula II, or a salt thereof, with a metal catalyst and hydrogen gas. 11. The process of claim 10 , wherein said metal catalyst is a ruthenium, rhodium, or palladium catalyst. 12. The process of claim 10 , wherein said metal catalyst is [(S)—BINAPRuCl(benzene)]Cl. 13. The process of claim 1 , wherein R 2 is an amino protecting group. 14. The process of claim 1 , wherein R 2 is C 1 -C 12 alkyl. 15. The process of claim 1 , wherein R 2 is isopropyl. 16. The process of claim 1 , wherein said reducing comprises reducing a compound of formula IIb, or a salt thereof: to form said compound of formula I or a salt thereof. 17. A compound of formula VI: or salt thereof, wherein: R 1 is hydrogen, acetyl, trifluoroacetyl, phthalimide, benzyl, triphenylmethyl, benzylidenyl, p-methoxybenzyl, tert-butyloxycarbonyl, 9-fluorenylmethyloxycarbonyl or carbobenzyloxy; R 2 is C 1 -C 12 alkyl; and R 5 is hydrogen or C 1 -C 12 alkyl. 18. The compound of claim 17 , wherein R 1 is hydrogen; R 2 is isopropyl; and R 5 is hydrogen or ethyl. 19. The compound of claim 17 , having the formula VIb: or a salt thereof wherein R 1 is hydrogen or t-butyloxycarbonyl. 20. The compound of claim 17 , wherein R 1 is t-butyloxycarbonyl. 21. A compound of formula VIb: or a salt thereof wherein R 1 is hydrogen or an amino protecting group.

Assignees

Inventors

Classifications

  • to carbon atoms of hydrocarbon radicals substituted by carboxyl groups · CPC title

  • the carbon skeleton containing six-membered aromatic rings · CPC title

  • by stereospecific synthesis · CPC title

  • by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups · CPC title

  • from amines with formation of carbamate groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9278917B2 cover?
The invention provides new processes for making and purifying amino acid compounds, which are useful in the preparation of AKT inhibitors used in the treatment of diseases such as cancer, including the compound (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one.
Who is the assignee on this patent?
Genentech Inc
What technology area does this patent fall under?
Primary CPC classification C07C67/343. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).